Why Has the DR Congo Ebola Outbreak Passed 5,000 Deaths? The Bundibugyo Strain, No Vaccine and the Spread Explained
Key Takeaways
- The Congolese health ministry's latest data records 5,026 deaths out of 10,351 infections since mid-May 2026, a lethality rate of nearly 50 per cent, with 2,788 recoveries.
- It is the deadliest Ebola outbreak in DRC history and the second-deadliest in the world, behind the 2014-2016 West Africa epidemic.
- The outbreak is caused by the rare Bundibugyo virus, first identified in Uganda in 2007, for which there are no approved vaccines or specific treatments.
- About 80 per cent of new cases come from outside known contact chains, and one-third of deaths happen outside treatment centres before testing.
- Cases linked to the outbreak have been confirmed in Kenya and Nigeria, and earlier in Uganda, making it Africa's most geographically widespread Ebola outbreak on record.
The DR Congo Ebola outbreak deaths pass 5,000, according to the latest data from the Congolese Ministry of Health, marking a grim milestone in an epidemic that has now infected more than 10,000 people since it was declared in mid-May 2026. The figures, reported by the Associated Press on Saturday, 31 October 2026, put the death toll at 5,026 out of 10,351 infections — a lethality rate of nearly 50 per cent. It is now the deadliest Ebola outbreak ever recorded in the Democratic Republic of the Congo (DRC), and the second-deadliest in the world, behind only the 2014–2016 West Africa epidemic that killed more than 11,000 people.
The milestone matters beyond the numbers. It shows an outbreak that health authorities have struggled to control for almost six months, in a region battered by conflict, displacement and distrust of health workers — and it comes as cases linked to the outbreak have now been confirmed in Kenya and Nigeria, raising fears of wider spread across Africa.
What the latest figures show
The Congolese health ministry's latest data, published on Saturday, records 5,026 deaths and 10,351 infections since the outbreak was declared in mid-May 2026. A total of 2,788 people have recovered, according to the same data. Al Jazeera, citing government data announced on Friday, also reported that the death toll had passed 5,000, while the World Health Organization (WHO) had earlier in the week put the figures at 10,141 cases and nearly 5,000 deaths as of Monday — consistent with the toll crossing 5,000 in the days that followed.
The outbreak has spread to 67 of the country's 178 health zones across eight of its 26 provinces, the Associated Press reported, with 50 of those zones still recording active cases. The epicentre remains the east of the country: Ituri and North Kivu provinces together account for 9,782 confirmed cases and 4,792 deaths. The WHO has described this as the largest Ebola outbreak in the DRC's history — the country's 17th — and the second-largest in the world after West Africa in 2014–2016, which infected more than 28,600 people.
"It is a very tragic milestone because it is just not a number," Dr Patrick Otim, a programme area manager with the WHO, told the Associated Press. "It is families and communities that have been devastated by this outbreak. The number also shows the severity of this outbreak."
Why the DR Congo Ebola outbreak deaths passed 5,000
No single cause explains the toll. Instead, several problems have compounded one another since May, and together they explain why a disease that is preventable in principle has kept killing.
First, a large share of infections is never caught in time. About 80 per cent of new cases are coming from outside the chain of monitored contacts, according to the Africa Centres for Disease Control and Prevention — meaning most new infections arise from chains of transmission that health workers do not know about. Contact tracing and testing, the two tools that stop Ebola spreading, are still struggling to keep up.
Second, one-third of recorded deaths are people who died outside treatment centres, before ever being tested for Ebola, the WHO's Dr Otim said. "These are people we never had opportunity to try to save them and it is one of the biggest concerns for us in this outbreak," he said. "How do we try to reach people early to get them to come to health facilities to get a fighting chance to survive?" People who die at home, and are buried without safe procedures, can also pass the virus on to family members.
Third, the response itself has been disrupted. The outbreak is concentrated in eastern DRC, where the government is fighting armed groups — most prominently the Rwanda-backed M23 rebel group — and where an Islamist insurgency operates near the Ugandan border. Conflict limits where health workers can safely go. Widespread disbelief about the disease has also led to attacks on health workers and facilities: a nurse was killed last week while responding to an Ebola alert, and a politician from the ruling party was killed in September after advocating for health measures on the radio.
Fourth, health workers have repeatedly gone on strike over unpaid wages, shutting down facilities where infected people are treated. On Friday, workers at an Ebola treatment centre in Tchomia, in Ituri, stopped work demanding four months of unpaid wages, while five confirmed patients and ten suspected cases were under care there. Similar stoppages have hit treatment centres in Beni, in North Kivu, where an elected official said cases were spiralling because of a lack of fuel and money from the central government.
"Across Ituri and North Kivu, this outbreak is stretching everyone responding to it, including the communities themselves," said Rose Tchwenko, country director for the DRC at Prosper Global, formerly Mercy Corps.
What is the Bundibugyo strain — and why is there no vaccine?
This outbreak is caused by the Bundibugyo virus, a rare species of Ebola virus first identified in 2007 during an outbreak in Bundibugyo district in western Uganda. It is one of four Ebola virus species known to cause disease in humans, alongside the Zaire, Sudan and Taï Forest species.
The crucial difference from the better-known Zaire strain is medical: there are no approved vaccines or specific treatments for the Bundibugyo virus. The vaccines developed during and after the West Africa epidemic target the Zaire strain, and they do not cover Bundibugyo. Health workers therefore treat patients based on their symptoms — fluids, oxygen and treatment of complications — rather than with a drug that attacks the virus itself.
That gap is now the focus of research. The WHO has noted that trials known as TUMAINI — Swahili for "hope" — will test whether the Evebro vaccine used against the Zaire strain can provide any protection in the current crisis. The WHO has also declared the outbreak in the DRC and Uganda a public health emergency of international concern, its highest alert level, underlining that the crisis is not a local problem alone.
How Ebola spreads — and how it does not
Ebola is not an airborne disease, and that distinction matters for how worried the rest of the world should be. According to the WHO, the Bundibugyo virus spreads from person to person through direct contact with the blood or other bodily fluids of someone who is sick with, or has died from, the disease, or through objects and surfaces contaminated with those fluids. It is believed to have animal origins, with fruit bats suspected to be among its natural reservoirs, and it can pass to humans through contact with infected animals.
The incubation period ranges from two to 21 days, and people are usually not infectious until symptoms begin. Early symptoms resemble flu or malaria — sudden fever, fatigue, muscle pain, headache and sore throat — which is one reason cases are hard to spot early in areas where those illnesses are common. Later symptoms can include vomiting, diarrhoea, abdominal pain and, in severe cases, internal and external bleeding and organ failure.
Because transmission needs direct contact with fluids, casual contact — sitting near someone, or breathing the same air — does not spread Ebola. That is why outbreaks are fought with isolation of patients, safe burials, contact tracing and protective equipment, rather than with the kind of population-wide measures used against respiratory viruses.
How far has the outbreak spread?
Within the DRC, the outbreak began in Ituri province in the north-east, a commercial and migratory hub bordering South Sudan and Uganda, and has since reached eight provinces. But the latest milestone has drawn attention because the outbreak has now crossed borders in a way no previous Ebola outbreak has: cases have been recorded in three African regions, making it the continent's most geographically widespread outbreak on record.
In October, Kenya confirmed cases of Ebola, with eight cases and two deaths reported by the Associated Press; the WHO's earlier update put Kenya's count at nine cases, including two deaths, all linked to the country's first case, a Kenyan citizen who had lived in the DRC for seven years. Nigeria confirmed a single case, a patient who was evacuated to Switzerland. Cases were also recorded earlier in Uganda. The WHO has said progress is being made — more than 2,600 people had recovered by its earlier update, and testing and treatment capacity has expanded — but the cross-border cases show how easily a single undetected traveller can carry the virus to a new country.
What happens next — and what it means for India
No cases linked to this outbreak have been reported in India in the coverage so far, and Ebola's transmission pattern means the risk from casual travel contact is low. The concern for the wider world is different: whether health systems in the affected region can find cases faster, reach patients earlier, and keep treatment centres staffed and paid — and whether a vaccine or treatment for Bundibugyo can be proven to work before the outbreak grows further.
For readers in India, the practical guidance from the WHO remains simple and general: Ebola spreads only through direct contact with the bodily fluids of a symptomatic patient or a person who has died from the disease, not through air, water or casual contact. Anyone developing fever and other symptoms after possible exposure — for instance, after travel to an affected area or contact with a known case — should seek medical attention promptly and mention the exposure, so that testing and isolation can happen early. Early care is the single biggest factor in survival: with supportive treatment, thousands have already recovered in this outbreak.
The next numbers to watch are not just the death toll but the share of new cases found inside known contact chains, the number of deaths occurring outside treatment centres, and the results of the TUMAINI vaccine trials. If contact tracing improves and fewer people die before reaching care, the outbreak can be bent downward even without a Bundibugyo-specific vaccine. If those indicators stay where they are, the toll will keep rising — and the 5,000 mark will be remembered as a warning that came too late.
Conclusion
The DR Congo Ebola outbreak passing 5,000 deaths is a milestone that says less about one virus than about everything around it: a rare strain with no approved vaccine, an eastern region at war, health workers unpaid and attacked, and a contact-tracing system that is missing four out of five new infections. The 2,788 recoveries show that survival is possible with early care. The challenge now is making early care reach everyone — before the next milestone arrives.